Documents › 3a0160e9792366039c4c24908c2d7e1cb47c0353:1-73

NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users

POST board policyreference 2022-12 73 pages (file pages 1–73) original file
About this document
Layer
attachment: a document a meeting packet links to
Type as titled
publication (kind from doc_type)
File
3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
Cases
POST 2313715 · Jaime Bermudez (filed under case)

About: Jaime Bermudez (case)

Page 51 · file page 51 larger image
Image of page 51; its text is alongside
Text: OCR

among both trauma center and ME driver cases during the day than at night. These findings are potentially useful because they underscore that drugs other than alcohol may play an important role in daytime traffic safety problems when alcohol use tends to be less prevalent.

While this report focused on presence/absence of drugs in a specimen, the quantification of drug concentrations has the potential to provide additional insights. A brief analysis of the alcohol concentration results found that 83.4% of the trauma center driver cases and 87.0% of the ME driver cases that were alcohol-positive had BACs at or above .08 g/dL, which is the illegal limit in all States except Utah where the limit is .05 g/dL. Concentration ranges were also examined for active THC and it was found that among those who tested positive, 80.0% of the trauma center driver cases and 86.4% of the ME driver cases had active THC concentrations at or above 2 ng/mL, which could be indicative of recent use, especially among occasional users. Given the average time from crash to blood draw in this study and what is known about the metabolism of cannabis, it is difficult to know with certainty when a THC-positive driver actually consumed the cannabis or the driver's blood concentration at the time of the crash. To address these uncertainties, more research is needed on the cannabis and driving topic to better understand how this drug could be affecting traffic safety given the prevalence levels observed here.

Overall, the results included in this report represent a first look at drug prevalence among a sample of seriously or fatally injured roadway users. Future research can analyze the data collected by this study to explore many more topics of interest. The study also sets an example by which future similar research can be conducted at other sites across the country. The participating Level 1 trauma centers and MEs were able to enact the study protocols without issue, even during the COVID-19 public health emergency. Future similar research at these sites or others across the country will be of particular use for monitoring changes in drugged driving over time, and will allow NHTSA and other traffic safety stakeholders to better tailor impaired driving countermeasures for particular regions or types of road users.

43

Keys: ← → or j k turn pages; / finds.